Comment
doi: 10.1503/cmaj.081744.
The controversy over the efficacy of pneumococcal vaccine
Affiliations
- PMID: 19124781
- PMCID: PMC2612055
- DOI: 10.1503/cmaj.081744
Item in Clipboard
Comment
The controversy over the efficacy of pneumococcal vaccine
CMAJ.
.
No abstract available
Comment in
-
Efficacy of pneumococcal polysaccharide vaccine.CMAJ. 2009 May 26;180(11):1134-5; author reply 1135. doi: 10.1503/cmaj.1090018. CMAJ. 2009. PMID: 19468126 Free PMC article. No abstract available.
Comment on
-
Efficacy of pneumococcal vaccination in adults: a meta-analysis.CMAJ. 2009 Jan 6;180(1):48-58. doi: 10.1503/cmaj.080734. CMAJ. 2009. PMID: 19124790 Free PMC article.
Similar articles
-
Streptococcus pneumoniae serotype 3 is masking PCV13-mediated herd immunity in Canadian adults hospitalized with community acquired pneumonia: A study from the Serious Outcomes Surveillance (SOS) Network of the Canadian immunization research Network (CIRN).Vaccine. 2019 Aug 23;37(36):5466-5473. doi: 10.1016/j.vaccine.2019.05.003. Epub 2019 Jul 23. Vaccine. 2019. PMID: 31345638
-
Economic evaluation of a universal childhood pneumococcal conjugate vaccination strategy in Ireland.Value Health. 2008 Sep-Oct;11(5):898-903. doi: 10.1111/j.1524-4733.2008.00341.x. Epub 2008 May 16. Value Health. 2008. PMID: 18489504
-
Estimated impact of revising the 13-valent pneumococcal conjugate vaccine schedule from 2+1 to 1+1 in England and Wales: A modelling study.PLoS Med. 2019 Jul 3;16(7):e1002845. doi: 10.1371/journal.pmed.1002845. eCollection 2019 Jul. PLoS Med. 2019. PMID: 31269018 Free PMC article.
-
Herd effects of child vaccination with pneumococcal conjugate vaccine against pneumococcal non-invasive community-acquired pneumonia: What is the evidence?Hum Vaccin Immunother. 2017 May 4;13(5):1177-1181. doi: 10.1080/21645515.2016.1264548. Epub 2016 Dec 12. Hum Vaccin Immunother. 2017. PMID: 27937061 Free PMC article. Review.
-
Indirect (herd) protection, following pneumococcal conjugated vaccines introduction: A systematic review of the literature.Vaccine. 2017 May 19;35(22):2882-2891. doi: 10.1016/j.vaccine.2017.04.032. Epub 2017 Apr 24. Vaccine. 2017. PMID: 28449971 Review.
Cited by
-
Acute organ injury and long-term sequelae of severe pneumococcal infections.Pneumonia (Nathan). 2023 Mar 5;15(1):5. doi: 10.1186/s41479-023-00110-y. Pneumonia (Nathan). 2023. PMID: 36870980 Free PMC article. Review.
-
Heterogeneity of the efficacy of the 23-valent pneumococcal polysaccharide vaccine caused by various underlying conditions of chronic pulmonary disease in older patients: prospective cohort study.BMJ Open. 2011 Jul 18;1(1):e000105. doi: 10.1136/bmjopen-2011-000105. BMJ Open. 2011. PMID: 22021764 Free PMC article.
-
Efficacy of pneumococcal polysaccharide vaccine.CMAJ. 2009 May 26;180(11):1134-5; author reply 1135. doi: 10.1503/cmaj.1090018. CMAJ. 2009. PMID: 19468126 Free PMC article. No abstract available.
References
-
- Moberley SA, Holden J, Tatham DP, et al. Vaccines for preventing pneumococcal infection in adults. Cochrane Database Syst Rev 2008;(1):CD000422. - PubMed
-
- Kaufman P. Pneumonia in old age. Arch Intern Med 1947;79:518-31. - PubMed
-
- Riley ID, Tarr PI, Andrews M, et al. Immunisation with a polyvalent pneumococcal vaccine. Reduction of adult respiratory mortality in a New Guinea Highlands community. Lancet 1977;1:1338-41. - PubMed
-
- Honkanen PO, Keistinen T, Miettinen L, et al. Incremental effectiveness of pneumococcal vaccine on simultaneously administered influenza vaccine in preventing pneumonia and pneumococcal pneumonia among persons aged 65 years or older. Vaccine 1999;17:2493-500. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
